Research on cancer prevention, detection and management in low- and medium-income countries

Annals of Oncology

Volumn 21, Issue 10, 2010, Pages 1935-1943

  Sankaranarayanan, R ^a   Boffetta, P ^b,c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

Cancer control; Cancer research; Clinical research; Early detection; Primary prevention; Screening

Indexed keywords

ACETIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; HELICOBACTER PYLORI VACCINE; HEPATITIS B VACCINE; WART VIRUS VACCINE;

ALCOHOL CONSUMPTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DIETARY INTAKE; DRUG EFFICACY; EARLY DIAGNOSIS; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HELICOBACTER INFECTION; HEPATITIS B; HUMAN; LEUKEMIA; LIFESTYLE; LIVER CANCER; LOWEST INCOME GROUP; LUNG CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MIDDLE INCOME GROUP; MOUTH CANCER; MULTIPLE MYELOMA; PATIENT ATTITUDE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SMOKING CESSATION; SOCIAL STATUS; STOMACH CANCER; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS;

EID: 77957112422     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq049     Document Type: Review

References (61)

1. World Health Organization. National Cancer Control Programmes. Policies and Managerial Guidelines. Geneva, Switzerland: WHO 2002.
2. International Agency for Research on Cancer. Aflatoxins. In: IARC Monographs of the Evaluation of Carcinogenic Risks to Humans, Vol. 82, Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. Lyon, France: IARC 2002; 171-300.
3. International Agency for Research on Cancer. Hepatitis B virus. In: IARC Monographs of the Evaluation of Carcinogenic Risks to Humans, Vol. 59, Hepatitis Viruses. Lyon, France: IARC 1994; 45-164.
4. International Agency for Research on Cancer. Infection with schistosomes. In: IARC Monographs of the Evaluation of Carcinogenic Risks to Humans, Vol. 61, Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France: IARC 1994; 45-119.
5. International Agency for Research on Cancer. Infection with liver flukes. In: IARC Monographs of the Evaluation of Carcinogenic Risks to Humans, Vol. 61, Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France: IARC 1994; 121-175.
6. But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 2008; 14: 1652-1656.
7. Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer 2007; 111: 145-153.
8. Kwok A, Lam T, Katelaris P, Leong RW. Helicobacter pylori eradication therapy: indications, efficacy and safety. Expert Opin Drug Saf 2008; 7: 271-281.
9. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
10. International Agency for Research on Cancer. Tobacco smoke. In: IARC Monographs of the Evaluation of Carcinogenic Risks to Humans, Vol. 83, Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC 2004; 51-1187.
11. International Agency for Research on Cancer. Smokeless tobacco. In: IARC Monographs of the Evaluation of Carcinogenic Risks to Humans, Vol. 89, Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. Lyon, France: IARC 2007; 39-417.
12. Boffetta P, Hashibe M, La Vecchia C et al. The burden of cancer attributable to alcohol drinking. Int J Cancer 2006; 119: 884-887.
13. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044.
14. Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006; 28: 126-135.
15. Ni YH, Huang LM, Chang MH et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007; 132: 1287-1293.
16. Koutsky LA, Harper DM. Chapter 13. Current findings from prophylactic HPV vaccine trials. Vaccine 2006; 24 (Suppl 3): S114-S121.
17. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356: 1915-1927.
18. Agosti J, Goldie S. Introducing HPV vaccine in developing countries-key challenges and issues. N Engl J Med 2007; 356: 1908-1910.
19. Parkin DM, Sitas F, Chirenje M et al. Part I: Cancer in Indigenous Africans-burden, distribution, and trends. Lancet Oncol 2008; 9: 683-692.
20. Siemiatycki J, Richardson L, Boffetta P. Occupation. In: Schottenfeld D, Fraumeni JF (eds), Cancer Epidemiology and Prevention. 3rd edition. New York: Oxford University Press 2006; 322-354.
21. Pearce N, Matos E, Vainio H et al. (eds) Occupational Cancer in Developing Countries. IARC Scientific Publications No. 129. Lyon, France: IARC 1994.
22. International Agency for Research on Cancer. Salted fish. In: IARC Monographs of the Evaluation of Carcinogenic Risks to Humans, Vol. 56, Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. Lyon, France: IARC 1993; 41-82.
23. Bonovas S, Tsantes A, Drosos T, Sitaras NM. Cancer chemoprevention: a summary of the current evidence. Anticancer Res 2008; 28: 1857-1866.
24. Franceschi S, Montella M, Polesel J et al. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev 2006; 15: 683-689.
25. Tran GD, Sun XD, Abnet CC et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005; 113: 456-463.
26. Nasrollahzadeh D, Kamangar F, Aghcheli K et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 2008; 98: 1857-1863.
27. Hakami R, Mohtadinia J, Etemadi A et al. Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer 2008; 60: 216-221.
28. Blot WJ, McLaughlin JK, Fraumeni JF. Esophageal cancer. In: Schottenfeld D, Fraumeni JF (eds), Cancer Epidemiology and Prevention. 3rd edition. New York: Oxford University Press 2006; 697-706.
29. Pourshams A, Saadatian-Elahi M, Nouraie M et al. Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer 2005; 92: 176-181.
30. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002-Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. Lyon, France: IARCPress 2004.
31. International Agency for Research on Cancer. Cervix Cancer Screening. IARC Handbooks on Cancer Prevention. Vol. 10. Lyon, France: IARC 2005.
32. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ 2001; 79(10): 954-962.
33. Sankaranarayanan R, Gaffikin L, Jacob M et al. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet 2005; 89 (Suppl 2): S4-S12.
34. SankaranarayananR, WesleyR. A PracticalManual on Visual Screening forCervical Neoplasia. IARC Technical Publication No. 41. Lyon, France: IARC Press 2003.
35. Blumenthal PD, Lauterbach M, Sellors JW, Sankaranarayanan R. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet 2005; 89 (Suppl 2): S30-S37.
36. Sankaranarayanan R, Esmy PO, Rajkumar R et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 2007; 370: 398-406.
37. Koliopoulos G, Arbyn M, Martin-Hirsch P et al. Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol 2007; 104: 232-246.
38. Denny L, Kuhn L, De SM et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005; 294: 173-181.
39. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 2003; 361: 814-820.
40. Sankaranarayanan R, Rajkumar R, Esmy PO et al. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer 2007; 96: 738-743.
41. Goldie S, Gaffikin L, Goldhaber-Fiebert J et al. Cost effectiveness of cervical screening in five developing countries. N Engl J Med 2005; 353: 2158-2168.
42. World Health Organization. Comprehensive Cervical Cancer Control. A Guide to Essential Practice. Geneva, Switzerland: WHO 2006.
43. Alliance for Cervical Cancer Prevention. Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers. Seattle, WA: ACCP 2004.
44. Sankaranarayanan R, Thara S, Esmy PO, Basu P. Cervical cancer: screening and therapeutic perspectives. Med Princ Pract. 2008; 17: 351-364.
45. Pisani P, Parkin DM, Ngelangel C et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006; 118: 149-154.
46. Thomas DB, Gao DL, Ray RM et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002; 94: 1445-1457.
47. Warnakulasuriya KAAS, Ekanayake ANI, Sivayoham S et al. Utilisation of primary care workers for early detection of oral cancer and precancer cases in Sri Lanka. Bull World Health Organ 1984; 62: 243-250.
48. Warnakulasuriya KAAS, Nanayakkara BG. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. Cancer Detect Prev 1991; 15: 331-334.
49. Mehta FS, Gupta PC, Bhonsle RB et al. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev 1986; 9: 219-225.
50. Mathew B, Sankaranarayanan R, Sunilkumar KB et al. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer 1997; 76: 390-394.
51. Sankaranarayanan R, Fernandez Garrotte L, Lence Anta J et al. Visual inspection in oral cancer screening in Cuba: a case-control study. Oral Oncol 2002; 38: 131-136.
52. Sankaranarayanan R, Ramadas K, Thomas G et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 2005; 365: 1927-1933.
53. Devi BC, Tang TS, Corbex M. Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 2007; 18: 1172-1176.
54. Jayant K, Rao RS, Nene BM, Dale PS. Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian population. Int J Cancer 1995; 63: 161-163.
55. Barton MB, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 2006; 7: 584-595.
56. http://cancer.iaea.org/ (16 August 2008, date last accessed).
57. http://www.iarc.fr (16 August 2008, date last accessed).
58. http://www.inctr.org (16 August 2008, date last accessed).
59. http://www.actrec.gov.in (12 August 2008, date last accessed).
60. http://www.who.int/tobacco/mpower/en/ (12 August 2008, date last accessed).
61. Magrath I. Building capacity for cancer control in developing countries: the need for a paradigm shift. Lancet Oncol 2007; 8: 562-563.